Maud Descamps takes stock of a current economic issue. As vaccine prices rise, Sanofi is now betting everything on messenger RNA. The French laboratory has bought several billion euros from an American specialist in this technology, Translate Bio. Messenger RNA, widely revealed by the coronavirus, may be useful for new discoveries: in particular vaccines against certain cancers.